BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


April Archive 2004 - have your press release here?

Dowpharma Announces Biologics Peptide Manufacture 

Scientists & Industry experts look to the future in the post-genome era

Fluoroquinolone use set to increase, despite resistance warnings

Pinnacle BIO Consulting launches BioOncology2004: Shifting Paradigms in Anticancer Therapeutics

Merckle demonstrate superior safety of Licofelone the first dual COX/LOX

Northbank Communications is Fastest Growing PR Consultancy in UK

HU-320 identified as a novel synthetic cannabinoid with therapeutic activity in an experiment model of rheumatoid arthritis

Dowpharma Signs Agreement for Drug Solubilization Feasibility Studies with Bristol-Myers Squibb 

Biotech Insight: Alert on ConjuChem, Type II Diabetes and GLP

An increasing incidence of HIV/HBV co-infection calls for more effective treatment

Drug delivery technology predicted to allow safer and more effective use of steroids in the treatment of rheumatoid arthritis

Agilent Technologies and Partners HealthCare Announce Technology Supply Agreement for Mass General, Brigham and Women's Hospitals

Agilent Technologies Donates Microarray Technology to Rhodes

Norak Biosciences And SCYNEXIS Announce Chemistry Collaboration

Eco-Safe Technical Services Ltd launches its Speci-Pak range of Diagnostic Specimen Packaging

Inpharmatica announces agreement with Biotica Technology to provide comprehensive ADME support to their natural products programmes

NicOx's nitrosulindac (NCX 1102) emerges as a candidate treatment of bladder cancer

Gene silence to set to quieten neuropathic pain - Novartis research expands the potential of siRNA

Novo Nordisk publish data demonstrating proof of concept for potassium channel openers as treatments of diabetes

BioPortfolio: Biotech Insight, DailyUpdates, New Reports, Infectious Diseases resources

New Microscopy Imaging Software European Preview on Syncroscopy Stand 351 at Analytica 2004

World’s Most Precise Colony Counter Presented by Synbiosis on Stand 452 at Analytica 

Eli Lilly's Duloxetine set to become the first widely used therapeutic treatment of stress urinary incontinence

New data shows that intensive treatment of diabetes may lower coexistent hypertension and delay renal dialysis by up to 20 years

Links between obesity/diabetes & Alzheimer disease

Curacyte AG Presents Positive Phase II Clinical Trial Results For PHP In The Treatment Of Distributive Shock

BioTech Stock Report: What Gives?

RZPD GmbH and Protagen AG agree on license

Eli Lilly’s Alimta to change the treatment dynamics in non-small cell lung cancer

Type 2 diabetes as a risk factor for Alzheimer's disease - defective insulin-degrading enzyme as an etiological link? 

GANYMED names Rainer Wessel Ph.D. as President & CEO

GREES publish new recommendations on the clinical development of disease modifying osteoarthritis drugs (DMOADs)

 

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.